Filter
1669
Text search:
marketing
Featured
119
494
Language
Document type
877
317
200
95
83
44
25
10
8
6
2
2
Countries
83
63
58
58
46
36
34
34
33
30
30
28
27
27
26
23
23
21
20
20
18
17
16
16
16
15
15
13
13
13
12
11
11
10
9
9
9
8
8
8
7
6
6
6
6
6
6
5
5
5
5
5
5
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
762
108
105
100
97
32
25
Toolboxes
122
97
86
78
71
53
37
36
35
33
27
26
25
25
25
23
16
12
11
10
10
9
5
4
1
1
1
First Revised Edition
March 2000
THE REPUBLIC OF BOTSWANA | MINISTRY OF HEALTH | DEPARTMENT OF PUBLIC HEALTH | NATIONAL MALARIA CONTROL PROGRAMME
The EHSP in Botswana seeks to attain universal coverage of high-quality package of essential health services. The EHSP is an integrated collection of cost-effective interventions, promotive, preventive, curative, and rehabilitative, that address the main diseases, injuries and risk factors that affe
...
The technical note from the Global Task Force on Cholera Control (GTFCC) examines the risks and benefits of vaccinating pregnant women with WHO-prequalified oral cholera vaccines (OCVs) during mass vaccination campaigns. It highlights that three WHO-approved vaccines (Dukoral®, Shanchol™, and Euv
...
Accessed November 2, 2017
Accessed November, 2017
Drug Advisory Board
This guideline is intended to provide requirements to applicants wishing to submit
applications for registration of medicines in Botswana.
Act 851 | AN ACT to revise and consolidate the law relating to public health to
prevent disease, promote, safeguard, maintain and protect the health
of humans and animals and to provide for related matters.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
MMWR. Recommendations and Reports:
December 16, 2005 / 54(RR15);49-55
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
